Fujian Wanchen Biotechnology Stock Beta
| 300972 Stock | 79.20 0.92 1.18% |
Fujian Wanchen Biotechnology fundamentals help investors to digest information that contributes to Fujian Wanchen's financial success or failures. It also enables traders to predict the movement of Fujian Stock. The fundamental analysis module provides a way to measure Fujian Wanchen's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Fujian Wanchen stock.
Fujian | Beta |
Fujian Wanchen Biotechnology Company Beta Analysis
Fujian Wanchen's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Fujian Wanchen Beta | -0.037 |
Most of Fujian Wanchen's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Fujian Wanchen Biotechnology is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, Fujian Wanchen Biotechnology has a Beta of -0.037. This is 103.01% lower than that of the Food Products sector and 107.55% lower than that of the Consumer Staples industry. The beta for all China stocks is 75.33% lower than that of the firm.
Fujian Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Fujian Wanchen's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Fujian Wanchen could also be used in its relative valuation, which is a method of valuing Fujian Wanchen by comparing valuation metrics of similar companies.Fujian Wanchen is currently under evaluation in beta category among its peers.
As returns on the market increase, returns on owning Fujian Wanchen are expected to decrease at a much lower rate. During the bear market, Fujian Wanchen is likely to outperform the market.
Fujian Fundamentals
| Return On Equity | 0.37 | ||||
| Return On Asset | 0.0902 | ||||
| Profit Margin | 0 % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 13.36 B | ||||
| Shares Outstanding | 179.48 M | ||||
| Shares Owned By Insiders | 59.75 % | ||||
| Shares Owned By Institutions | 5.62 % | ||||
| Price To Book | 15.43 X | ||||
| Price To Sales | 0.57 X | ||||
| Revenue | 9.29 B | ||||
| Gross Profit | 87.15 M | ||||
| EBITDA | 757.15 M | ||||
| Net Income | (82.93 M) | ||||
| Total Debt | 510.77 M | ||||
| Book Value Per Share | 5.09 X | ||||
| Cash Flow From Operations | 1.02 B | ||||
| Earnings Per Share | 0.30 X | ||||
| Target Price | 80.63 | ||||
| Number Of Employees | 4.97 K | ||||
| Beta | -0.037 | ||||
| Market Capitalization | 13.31 B | ||||
| Total Asset | 3.93 B | ||||
| Retained Earnings | 92.75 M | ||||
| Working Capital | (290.99 M) | ||||
| Net Asset | 3.93 B |
About Fujian Wanchen Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Fujian Wanchen Biotechnology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Fujian Wanchen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Fujian Wanchen Biotechnology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin |
Other Information on Investing in Fujian Stock
Fujian Wanchen financial ratios help investors to determine whether Fujian Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Fujian with respect to the benefits of owning Fujian Wanchen security.